The Ritedose Corporation is recalling 3,795 syringes of Ritedose 23.4% Sodium Chloride Injection because the barcode on the syringe label is incorrect. The barcode mistakenly identifies the product as rocuronium bromide injection, a muscle relaxant, instead of sodium chloride. While the human-readable text on the label is correct, scanning the barcode could lead to medication errors. No incidents or injuries have been reported to date.
If healthcare providers rely on scanning the incorrect barcode for medication administration, they may inadvertently administer sodium chloride when rocuronium bromide was intended, or vice versa, leading to inappropriate treatment and potential patient harm.
The product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.